Related Experiment Video
Updated: Jun 8, 2025
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Melanoma Metabolism: Molecular Mechanisms and Therapeutic Implications in Cutaneous Oncology
Isabella J Tan1, Aarushi K Parikh1, Bernard A Cohen2
1Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Background:
Melanoma, a highly aggressive skin cancer, is characterized by rapid progression and a high metastatic potential, presenting significant challenges in clinical oncology. A critical aspect of melanoma biology is its metabolic reprogramming, which supports tumor growth, survival, and therapeutic resistance.
Objective:
This review aims to explore the key molecular mechanisms driving metabolic alterations in melanoma and their implications for developing therapeutic strategies.
Methods:
A Pubmed search was conducted to analyze literature discussing key mechanisms of the Warburg effect, mitochondrial dysfunction, enhanced lipid metabolism, epigenetic modifications, and the tumor microenvironment.
Results:
Metabolic reprogramming supports melanoma growth, proliferation, and survival. Understanding these complex metabolic dynamics provides valuable insights for developing targeted therapeutic strategies.
Conclusion:
Potential therapeutic interventions aimed at disrupting melanoma metabolism highlight the promise of precision medicine in improving treatment outcomes in cutaneous oncology. By targeting metabolic vulnerabilities, novel treatment approaches could significantly enhance the clinical management and prognosis of melanoma.
Insights
Melanoma cells reprogram their metabolism to fuel growth and resist treatment. Targeting these metabolic vulnerabilities offers a promising avenue for precision medicine in treating this aggressive skin cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Melanoma is an aggressive skin cancer with high metastatic potential.
- Metabolic reprogramming is crucial for melanoma tumor growth, survival, and drug resistance.
Purpose of the Study:
- To review key molecular mechanisms of metabolic alterations in melanoma.
- To explore the implications of these metabolic changes for therapeutic strategies.
Main Methods:
- Literature analysis of PubMed-indexed studies.
- Focus on Warburg effect, mitochondrial dysfunction, lipid metabolism, epigenetics, and tumor microenvironment.
Main Results:
- Metabolic reprogramming significantly supports melanoma growth, proliferation, and survival.
- Understanding melanoma's metabolic dynamics is key to developing targeted therapies.
Conclusions:
- Targeting melanoma metabolism presents a promising precision medicine approach.
- Disrupting metabolic vulnerabilities can improve treatment outcomes and patient prognosis in cutaneous oncology.
Related Concept Videos
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:22PI3K/mTOR/AKT Signaling Pathway